Esketamine disinhibits brain networks in depression: Evidence from oscillatory and aperiodic activity
- 5 July 2025
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 140, 111438
Abstract
No abstract availableKeywords
Funding Information
- Department of Psychiatry
- University of North Carolina
This publication has 66 references indexed in Scilit:
- Esketamine in depression: putative biomarkers from clinical researchEuropean Archives of Psychiatry and Clinical Neuroscience, 2024
- Characteristics of Esketamine Prescribers Among Medicare Beneficiaries in the United States, 2019-2020JAMA Network Open, 2023
- Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant DepressionClinical Pharmacokinetics, 2020
- Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding SchizophreniaJAMA Network Open, 2020
- Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophreniaHuman Brain Mapping, 2019
- Ketamine effects on default mode network activity and vigilance: A randomized, placebo‐controlled crossover simultaneous fMRI/EEG studyHuman Brain Mapping, 2019
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant DepressionJAMA Psychiatry, 2019
- Altered Structure of Dynamic Electroencephalogram Oscillatory Pattern in Major DepressionBiological Psychiatry, 2015
- Multistage drug effects of ketamine in the treatment of major depressionEuropean Archives of Psychiatry and Clinical Neuroscience, 2014
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major DepressionArchives of General Psychiatry, 2006